Udhayvir S. Grewal, MBBS, on DLL3: The New Frontier in Extrapulmonary Neuroendocrine Carcinomas
This video is being prepared and will be available shortly.
Udhayvir S. Grewal, MBBS, of Emory Winship Cancer Institute, discusses disease biology, classification, and current challenges associated with extrapulmonary neuroendocrine carcinomas (epNEC); the biologic and therapeutic role of DLL3 in these malignancies; how DLL3 is tested for and assessed; and the potential clinical implications of DLL3 expression in epNECs.